New targets of 'antiphospholipid' antibodies;Les nouvelles cibles des anticorps 'antiphospholipides'

Revue de Medecine Interne

Volumn 18, Issue 4, 1997, Pages 292-302

  Arvieux, J ^a   Darnige, L ^b   Sarrot Reynauld, F ^c  

^a Etablissement Transfus Sang l'I   (France)

^b Centre Hospitalier Compiegne   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

antiphospholipid syndrome; kininogens; prothrombin; 2 glycoprotein I

Indexed keywords

KININOGEN; PROTHROMBIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PATHOPHYSIOLOGY; REVIEW; THROMBOSIS;

EID: 0030976893     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)84014-3     Document Type: Article

References (69)

1. Bevers EM, Galli M, Barbui T et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:929-32
2. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;i:1544-7
3. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4
4. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other «antiphospholipid» autoantibodies. Blood 1994; 84:2854-67
5. Roubey RAS. Immunology of the antiphospholipid syndrome. Arthritis Rheum 1996;39:1444-54
6. Hörkkö S, Miller E, Dudl E et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996;98:815-25
7. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996;5:442-7
8. Piette JC. 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a «mission impossible»? Lupus 1996;5:354-63
9. Eschwege V, Freyssinet JM. Les anticorps antiphospholipides: cause ou conséquence de la stimulation ou de la mort cellulaire? Hématologie 1996;2:198-202
10. Gris JC, Toulon P, Brun S et al. The relationship between plasma microparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection. Thromb Haemost 1996;76:38-45
11. Carreras LO, Forastiero RR. Pathogenic role of antiproteinphospholipid antibodies. Haemostasis 1996;26(suppl 4):340-57
12. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78:1-31
13. 2 glycoprotein I complex is an antigen for anticardiolipin antibodies occuring in autoimmune disease but not with infection. Lupus 1992;1:75-81
14. 2-glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost 1996;75:717-20
15. 2GPI) enhances cardiolipin binding activity but is not the antigen for anti-phospholipid antibodies. Br J Haematol 1992;82:565-70
16. Roubey RAS. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus 1996;5:425-30
17. 2-glycoprotein I as an antigen. J Immunol Meth 1991;143: 223-9
18. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62
19. 2 glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995;155:1629-36
20. 2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995;73:29-34
21. 2-glycoprotein I in the absence of phospholipid: importance of antigen density and bivalent binding. J Immunol 1995;154:954-60
22. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992;68:297-300
23. 2-glycoprotein I. Thromb Haemost 1992;67:499-502
24. 2-glycoprotein I. J Clin Invest 1992;90:1100-4
25. 2 glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995;4:122-30
26. 2 glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906
27. 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost 1996;75:725-30
28. Amiral J, Adam M, Cluzeau D et al. Different target specificities of phospholipid-dependent antibodies. Ann Med Interne 1996;147(suppl 1):18-21
29. 2GPI) antibodies in systemic lupus erythematosus. Lupus 1995;4:472-6
30. 2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509-12
31. 2 glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1466-74
32. 2 glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994;95:310-5
33. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93:223-9
34. 2-glycoprotein I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995;34:1031-6
35. 2 glycoprotein I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471-3
36. 2-glycoprotein I in patients with primary antiphospholipid syndrome. J Rheumatol 1995;22:1894-8
37. 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-402
38. 2-glycoprotein I cofactors for antiphospholipid antibodies. Lupus 1996;5:388-92
39. Arvieux J, Darnige L, Caron C et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-5
40. Karmochkine M, Cacoub P, Piette JC et al. Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis. Clin Exp Rheum 1992;10:603-5
41. Berard M, Chantome R, Marcelli A, Boffa MC. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J Rheumatol 1996;23:1369-74
42. 2 glycoprotein I and anti-prothrombin antibodies. Nouv Rev Fr Hématol 1995;37(suppl II):S53-6
43. 2-glycoprotein I on binding to phospholipid. J Rheumatol 1994;21: 94-9
44. Bajaj SP, Rapaport SI, Fierer DS et al. A mechanism for the hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-92
45. Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood 1984;64:807-16
46. Fleck RA, Rapaport SI, Rao LVM. Antiprothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-9
47. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994;83:2878-92
48. Pengo V, Biasiolo A, Brocco T et al. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996;75:721-4
49. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995;86:617-23
50. 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. Ann Med Interne 1996;147(suppl I):42-3
51. Vaarala O, Puurunen M, Mänttäri M et al. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996;75:456-9
52. Vermylen J, Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med 1992;120:10-2
53. De Groot PG, Horbach DA, Derksen RHWM. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis. Lupus 1996;5:488-93
54. Oosting JD, Derksen RHWM, Bobbink IWG et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanisms? Blood 1993;81:2618-25
55. Smirnov MD, Triplett DT, Comp PC et al. On the role of phosphatidylethanolamme in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 1995;95:309-16
56. Falcon CR, Hoffer AM, Carreras LO. Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine antibodies. Thromb Res 1990;59:383-8
57. 2-glycoprotein I plasma levels. Autoimmunity 1993;16:245-9
58. Boffa MC, Berard M, Sugi T, McIntyre JA. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. J Rheumatol 1996;23:1375-9
59. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995;86:3083-9
60. Sugi T, McIntyre JA. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by anti-phosphatidylethanolamine antibodies. Thromb Haemost 1996;76:354-60
61. Sammaritano LR, Gharavi AE. Antiphospholipid antibodies and placental anticoagulant protein I. Lupus 1994;3:263-5
62. Matsuda J, Saitoh N, Gohchi K et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994;47:56-8
63. Nakamura N, Shidara Y, Kawaguchi N et al. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem Biophys Res Commun 1994;205:1488-93
64. 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684-93
65. Rand JH, Wu XX, Guller S et al. Reduction of annexin V (placental anticoagulant protein I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171: 1566-72
66. Shibata S, Harpel PC, Gharavi A et al. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994;83:2532-40
67. Rock G, Chauhan K, Jamieson GA et al. Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. Br J Haematol 1994;88:878-80
68. 2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of «non-self» particles. J Biol Chem 1995; 270:25845-9
69. 2 glycoprotein I antibodies in the antiphospholipid syndrome. J Rheumatol 1994;21:1678-83